NAM
EFTR

Nexpoint Asset Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Nexpoint Asset Management’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,544
Closed -$382K – 206
2021
Q2 		$382K Buy
1,544
+960
+164% +$238K 0.08% 107
2021
Q1 		$142K Buy
+584
New +$142K 0.04% 138